| For: | Wu J, Xue R, Jiang RT, Meng QH. Characterization of metabolic landscape in hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(9): 1144-1156 [PMID: 34616519 DOI: 10.4251/wjgo.v13.i9.1144] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i9/1144.htm |
| Number | Citing Articles |
| 1 |
Soo-Mi Kweon, Gayeoun Kim, Yunseong Jeong, Wendong Huang, Ju-Seog Lee, Keane K. Y. Lai. Midnolin Regulates Liver Cancer Cell Growth In Vitro and In Vivo. Cancers 2022; 14(6) doi: 10.3390/cancers14061421
|
| 2 |
Bin Bi, Liqin Tang, Ranxi Liang, Haijing Wu, Qilan Huang, Li Pan. MCT8 Modulates Metabolite Uptake and T-cell Exhaustion to Promote Immunosuppression and Tumor Progression in Hepatocellular Carcinoma. Molecular Cancer Therapeutics 2026; 25(5) doi: 10.1158/1535-7163.MCT-25-0564
|
| 3 |
Li Liu, Yi-Ning Li, Aimin Zhang, Yue Yin, Zhihong Yue, Lin Pei, Chang-Sheng Xia, Dong Wang, Mei Jia, Hui Wang, Lin-Lin Cao. Clinical potential of serum prostaglandin A2 as a novel diagnostic biomarker for hepatocellular cancer. Clinica Chimica Acta 2024; 561 doi: 10.1016/j.cca.2024.119814
|
| 4 |
Joseph C. Ahn. A Global Perspective on Metabolically Driven Primary Liver Cancer: Opportunities and Challenges. American Journal of Gastroenterology 2025; 120(10) doi: 10.14309/ajg.0000000000003282
|
| 5 |
Monika Komza, Jerry Edward Chipuk. Mitochondrial metabolism: A moving target in hepatocellular carcinoma therapy. Journal of Cellular Physiology 2025; 240(1) doi: 10.1002/jcp.31441
|
| 6 |
Lihua Wang, Guoqing Liu, Qilan Huang, Haijing Wu, Xinhan Cheng, Li Pan. CBX6 induces CD8+ T cell exhaustion and tumor development in esophageal squamous cell carcinoma through SMARCD1-mediated CCL8 secretion and lactate efflux. Cell Biology and Toxicology 2025; 41(1) doi: 10.1007/s10565-025-10102-x
|
| 7 |
NP Syamprasad, Siddhi Jain, Bishal Rajdev, Neethu Prasad, Ravindra Kallipalli, V.G.M. Naidu. Aldose reductase and cancer metabolism: The master regulator in the limelight. Biochemical Pharmacology 2023; 211 doi: 10.1016/j.bcp.2023.115528
|
| 8 |
Arthur J. L. Cooper, Thambi Dorai, John T. Pinto, Travis T. Denton. Metabolic Heterogeneity, Plasticity, and Adaptation to “Glutamine Addiction” in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase—ω-Amidase (Glutaminase II)] Pathway. Biology 2023; 12(8) doi: 10.3390/biology12081131
|
| 9 |
Chengnan Fang, Pengwei Guan, Huan Yang, Xiaokun Wang, Lei You, Qi Li, Xiaolin Wang, Yaorui Ye, Jinhu Fan, Guowang Xu, Youlin Qiao, Xinyu Liu. Metabolome-wide association study to decipher the risk of exogenous chemical exposure to liver cancer in a Chinese nested case-control cohort. Environment International 2026; 211 doi: 10.1016/j.envint.2026.110274
|
| 10 |
Hao Xu, Hui Pan, Lian Fang, Cangyuan Zhang, Chen Xiong, Weiti Cai. A glutamine metabolish-associated prognostic model to predict prognosis and therapeutic responses of hepatocellular carcinoma. Biology Direct 2024; 19(1) doi: 10.1186/s13062-024-00567-x
|
| 11 |
Xiaopei Peng, Zhenhu He, Dandan Yuan, Zhenguo Liu, Pengfei Rong. Lactic acid: The culprit behind the immunosuppressive microenvironment in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(5) doi: 10.1016/j.bbcan.2024.189164
|
| 12 |
Dong-Xu Liao, Xiang An, Gui-Xiang Huang, Tong-Ling Yuan. The impact of metabolic reprogramming in hepatocellular carcinoma on T cell. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1696113
|
| 13 |
Lingyu Huang, Junjun Guo, Wei Liu, Shenping Xie, Qiang Yan, Wenjun Pu, Zhipeng Zeng, Liusheng Lai, Baoyao Wang, Yong Dai, Donge Tang, Huaizhou Chen. SomaScan proteomics reveals novel biomarkers in the progression of liver cirrhosis to hepatocellular carcinoma. BMC Medical Genomics 2026; 19(1) doi: 10.1186/s12920-026-02398-3
|
| 14 |
Yuki Kuranaga, Yasmin Hatem, Hans E. Grossniklaus, Sameh S. Ali, Erwin G. Van Meir. The emerging role of metabolic interventions in uveal melanoma. Seminars in Cancer Biology 2025; 117 doi: 10.1016/j.semcancer.2025.10.002
|
| 15 |
Renumathy Dhanasekaran, Hiroyuki Suzuki, Lea Lemaitre, Naoto Kubota, Yujin Hoshida. Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making. Hepatology 2025; 81(3) doi: 10.1097/HEP.0000000000000513
|
| 16 |
Zhao Ruan, Xuedan Sun. Metabolic reprogramming and the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic targeting. Hepatoma Research 2026; doi: 10.20517/2394-5079.2025.58
|
| 17 |
Amna Hafeez, Zeeshan Khan, Muhammad Armaghan, Khushbukhat Khan, Eda Sönmez Gürer, Ahmad Faizal Abdull Razis, Babagana Modu, Zainab M. Almarhoon, William N. Setzer, Javad Sharifi-Rad. Exploring the therapeutic and anti-tumor properties of morusin: a review of recent advances. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1168298
|
| 18 |
Zhongming Bao, Ming Yang, Yunhu Guo, Qi Ge, Huaguo Zhang. MTFR2 accelerates hepatocellular carcinoma mediated by metabolic reprogramming via the Akt signaling pathway. Cellular Signalling 2024; 123 doi: 10.1016/j.cellsig.2024.111366
|
| 19 |
Anna Gajos-Michniewicz, Malgorzata Czyz. WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities. Genes & Diseases 2024; 11(2) doi: 10.1016/j.gendis.2023.02.050
|
| 20 |
Huihai Yang, Martina Mang Leng Lei, Longfei Xie, Yinuo Shou, Terence Kin Wah Lee. Deciphering adenosine signaling in hepatocellular carcinoma: Pathways, prognostic models, and therapeutic implications. Clinical and Molecular Hepatology 2025; 31(3) doi: 10.3350/cmh.2024.1068
|